TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS

Information

  • Research Project
  • 6283612
  • ApplicationId
    6283612
  • Core Project Number
    R41CA084688
  • Full Project Number
    5R41CA084688-02
  • Serial Number
    84688
  • FOA Number
    PAR-98-066
  • Sub Project Id
  • Project Start Date
    3/1/2000 - 24 years ago
  • Project End Date
    2/28/2002 - 22 years ago
  • Program Officer Name
    ZAIKA, ELLEN
  • Budget Start Date
    3/1/2001 - 23 years ago
  • Budget End Date
    2/28/2002 - 22 years ago
  • Fiscal Year
    2001
  • Support Year
    2
  • Suffix
  • Award Notice Date
    2/5/2001 - 23 years ago
Organizations

TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS

DESCRIPTION: (Applicant's Description) The goal of this project is to develop an exceptionally compact, high throughput tritium accelerator mass spectrometer (AMS) to enable ultra-sensitive tracer studies relevant to the molecular analysis of cancer. The proposed tritium AMS will operate at much lower energy than existing multi-isotope AMS instruments, and will incorporate a sample inlet that can be coupled to a wide variety of liquid micro-flow sample preparation systems. AMS is a powerful tool for detection of rare isotopes such as tritium that are commonly used to radiolabel organic biomolecules, with detection limits in the attomole (10exp-18 mole) and lower range. In contrast to existing instrumentation, an AMS designed exclusively for detection of tritium may be as compact and inexpensive as conventional mass spectrometers. As currently practiced, analysis of biological samples by AMS is limited by the requirement for highly specialized sample preparation procedures that are not compatible with on-line and rapid detection applications. The instrument proposed here addresses this shortcoming by integrating a specialized sample interface into the overall design. The goals of Phase I are to develop and optimize the interface, to experimentally determine the feasibility of tritium AMS at very low energy, and to develop a design to be implemented in Phase II. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R41
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    191703
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
  • Funding ICs
    NCI:191703\
  • Funding Mechanism
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NEWTON SCIENTIFIC, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02141
  • Organization District
    UNITED STATES